Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New grief therapy aims to help parents find meaning after losing a child

NCT ID NCT02153619

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new counseling program called Meaning-Centered Grief Therapy (MCGT) for parents who have lost a child. The program focuses on helping parents find meaning and purpose after their loss. About 108 parents will take part, and the study will see if the therapy is practical and helps reduce symptoms of prolonged grief.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Meaning-Centered Grief Therapy (MCGT) and Supportive Psychotherapy (SP)
What this could lead to
If it works, this could provide an effective, structured therapy to help grieving parents find meaning and reduce prolonged grief symptoms.
What could go wrong
This is an early feasibility study with a small number of participants, so results may not apply to all parents. The therapy may not be more helpful than standard supportive counseling.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

108 people

The number who actually took part.

Started

May 2014

Expected to finish

May 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Loss of a child at least 6 months * Biological or adoptive parent or stepparent as reported in the child's medical record or by parent report * Parent must be age 18 or over as reported by parent * In the judgment of investigators/consenting professionals, able to comprehend English to complete study assessments * Score of 34 or greater ( ≥ 34) on the PG-13 at screening (N/A for training case participants) * Residing in New York, New Jersey, Connecticut, or Pennsylvania for P1S1; Residing in New York for P1S2; residing in New York or New Jersey or able to complete sessions while complying with current telehealth regulations. Support Provider Inclusion Criteria: * Must be age 18 or over as indicated by self-report * Has been identified by the bereaved parent participant as a support or someone important to bereaved parent * Must reside in New York or New Jersey or able to complete sessions while complying with current telehealth regulations. Exclusion Criteria: * Significant psychiatric disturbance sufficient, in the investigator's judgment, to preclude completion of the assessment measures, interview or informed consent * Inability to access a computer with Internet or inability to use a computer with Internet provided by the study as indicated by self-report * Another parent or primary caregiver of the child has been enrolled in the study (N/A for training case participants) * For the Part 2 RCT, participated in Part 1, Step 1 or 2. Support Provider Exclusion Criteria: * Significant psychiatric disturbance sufficient, in the investigator's judgment, to preclude completion of the assessment measures, interview or informed consent * Inability to access a computer with Internet or inability to use a computer with Internet provided by the study as indicated by self-report

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Parents who have lost A child are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Memorial Sloan Kettering Cancer Center

    New York, New York, 10065, United States